Tag: clinical trials

Background Traditional assessments of disease progression and intervention efficacy used in clinical trials are often limited. These assessments normally consist of clinical outcome assessments (COAs) and patient reported outcomes (PROs). COAs are physician-derived, often requiring patients to travel to a clinical site. They are typically subjective, episodic in nature, and provide limited insight into the […]

AWS re:Invent routinely fills several Las Vegas venues with standing-room only crowds, but we are bringing it to you with an all-virtual and free event this year. This year’s conference is gearing up to be our biggest yet and we have an exciting program planned with five keynotes, 18 leadership sessions, and over 500 breakout […]

Introduction Bio-pharmaceutical companies have always had a responsibility to report adverse events (AE), whether in clinical development or post market-approval scenarios, to the Food and Drug Administration (FDA).  The COVID-19 pandemic and the race to find effective treatments for this disease has caused both the FDA and bio-pharmaceutical organizations around the world to re-imagine the […]

Introduction Bringing a new drug to market is a slow and laborious process. According to Tufts Centre for the Study of Drug Development, it takes on average between 7 to 10 years and costs more than $2.5 billion to bring a new drug to market. (1) More than half of this time and capital is […]

Amazon Managed Blockchain is a fully managed service that makes it easy to create and manage scalable blockchain networks using popular open source frameworks, such as Hyperledger Fabric and Ethereum. General availability of Hyperledger Fabric was announced in April 2019, with support for Ethereum coming soon. For additional details about Managed Blockchain, see What Is Amazon […]